pathogen
action
mous
leukaemia
virus
difficult
studi
account
long
variabl
time
appear
leukaemia
use
inform
multipl
pathogenesi
virus
might
obtain
viru
could
found
modifi
pathogen
altern
pathogen
modifi
mous
hepat
viru
seem
suitabl
choic
investig
pathogen
action
stabl
predict
produc
mild
hepat
normal
weanl
mice
fatal
hepat
weanl
mice
recent
infect
eperythrozoon
coccoid
niven
gledhil
dick
andrew
bear
gener
resembl
mani
leukaemia
virus
eg
size
thermol
host
specif
cf
gledhil
dick
niven
moloney
experi
describ
undertaken
studi
dual
infect
mice
friend
molonev
leukaemia
agent
friend
moloney
found
prior
inocul
reduc
pathogen
friend
leukaemia
agent
fatal
hepat
result
hepat
viru
inocul
sever
day
friend
agent
latter
phenomenon
close
resembl
enhanc
e
coccoid
moloney
leukaemia
agent
also
enhanc
provid
inocul
preced
least
day
enhanc
somewhat
less
mark
enhanc
may
provid
use
method
titrat
moloney
agent
two
strain
white
mice
design
albani
swiss
use
bred
mani
year
farm
divis
laboratori
research
new
york
state
depart
health
albani
experi
day
old
mice
employ
term
babi
mice
experi
newli
wean
mice
age
day
g
use
term
weanl
mice
albani
mice
use
experi
show
enhanc
appear
suscept
swiss
mice
swiss
mice
employ
demonstr
moloney
leukaemia
limit
experi
suggest
develop
sooner
albani
mice
inocul
experi
describ
rout
inocul
intraperiton
inoculum
ml
weanl
mice
ml
unwean
mice
present
address
nation
institut
medic
research
mill
hill
london
diluent
tissu
suspens
inocul
storag
mixtur
equal
part
per
cent
salin
per
cent
hors
serum
broth
refer
ss
broth
friend
moloney
leukaemia
agent
obtain
lyophilis
tissu
suspens
dr
charlott
friend
dr
j
b
moloney
reconstitut
friend
agent
inocul
swiss
weanl
pass
per
cent
spleen
suspens
day
similar
mice
day
spleen
suspens
mice
pass
albani
weanl
kill
day
supernat
centrifug
per
cent
suspens
spleen
distribut
small
bottl
store
pool
use
experi
reconstitut
moloney
agent
inocul
pass
babi
swiss
mice
third
pass
use
lymph
node
suspens
mous
develop
leukaemia
day
supernat
centrifug
spleen
suspens
mi
centrifug
lymph
node
suspens
mous
store
separ
reconstitut
suspens
anoth
origin
ampoul
inocul
babi
swiss
mice
sacrif
day
liverspleen
suspens
inocul
similar
mice
one
develop
leukaemia
day
supernat
cycl
centrifug
suspens
lymph
node
thymu
employ
one
experi
other
mice
inocul
second
origin
ampoul
sacrif
day
suspens
spleen
lymph
node
inocul
babi
swiss
mice
one
sign
leukaemia
kill
day
lymph
node
suspens
mous
frozen
slowli
thaw
three
time
centrifug
supernat
store
use
anoth
experi
lyophilis
liverspleen
suspens
inocul
weanl
albani
mice
liverspleen
suspens
pass
weanl
albani
mice
kill
day
supernat
centrifug
per
cent
liverspleen
suspens
mice
distribut
bottl
store
experi
describ
mice
inocul
dilut
store
suspens
titrat
store
suspens
albani
mice
treat
two
day
previous
e
coccoid
show
ml
per
cent
suspens
contain
absenc
e
coccoid
inoculum
produc
mild
nonleth
hepat
weanl
albani
mice
weanl
mice
inocul
dose
kill
oin
day
unless
otherwis
state
surfac
liver
examin
bled
sever
aorta
liver
lesion
record
follow
way
coalesc
focal
lesion
give
generalis
liver
abnorm
liver
bright
yellow
background
haemorrhag
area
mous
dead
liver
appear
last
group
w
eanl
albani
mice
inocul
mhv
l
score
mostlv
score
quit
often
score
none
score
experi
mice
inocul
agent
abl
potenti
mhv
mice
score
regard
infect
potenti
agent
thu
e
coccoid
use
potenti
albanv
mice
half
dead
day
vtiru
inocul
remaind
score
method
adopt
indirect
titrat
agent
potenti
mhr
intraperiton
inocul
decim
dilut
agent
ss
broth
group
mice
usual
dose
follow
intraperiton
inocul
usual
dose
age
mice
use
inocul
potenti
agent
select
potenti
would
maxim
reach
day
age
inocul
weanl
mice
satisfi
condit
friend
agent
babi
mice
moloney
agent
group
inocul
mhvl
without
potenti
agent
also
includ
indic
mice
score
regard
infect
potenti
agent
calcul
proport
infect
dilut
bv
method
reed
muench
direct
titrat
group
mice
inocul
dilut
leukaemia
agent
indirect
titrat
friend
agent
kill
day
infect
mice
show
obviou
splenomegali
precis
spleen
heavier
g
consid
infect
weight
rather
doubl
averag
normal
spleen
g
fact
infect
spleen
much
heavier
g
mean
g
moloney
agent
mice
examin
daili
develop
easili
palpabl
lymph
node
kill
diagnosi
base
gross
lesion
termin
experi
survivor
kill
diagnosi
leukaemia
base
lesion
seen
autopsi
calcul
indirect
titrat
proport
infect
mice
diltut
preliminari
experi
inocul
group
weanl
swiss
mice
day
day
inocul
per
cent
spleen
suspens
contain
friend
agent
mice
kill
day
inocul
friend
agent
spleen
weigh
experi
repeat
weanl
mice
albani
strain
result
experi
shown
tabl
remark
unexpect
observ
high
mortal
hepat
albani
mice
inocul
six
day
friend
agent
although
one
swiss
mous
correspond
group
die
degre
hepat
manifest
autopsi
greater
produc
normal
swiss
mice
seen
mean
spleen
weight
strain
mice
inocul
day
day
friend
agent
group
receiv
friend
agent
except
albani
group
receiv
day
friend
agent
differ
fact
signific
level
probabl
contrast
mean
spleen
weight
mice
inocul
one
day
dav
friend
agent
group
given
friend
agent
anoth
experi
group
albani
mice
inocul
day
friend
agent
mortal
acut
hepat
mean
spleen
weight
survivor
group
receiv
mhv
day
friend
agent
g
less
group
receiv
friend
agent
g
experi
confirm
given
day
friend
agent
splenic
enlarg
due
latter
reduc
splenic
enlarg
lessen
mhv
given
period
one
day
day
friend
agent
mhv
l
given
six
day
friend
agent
splenic
enlarg
appar
reduc
evid
base
result
depict
tabl
experi
cite
togeth
other
show
inocul
weanl
albani
mice
friend
agent
preced
sever
day
pathogen
much
increas
follow
experi
enhanc
pathogen
use
indirect
mean
titrat
friend
agent
result
compar
direct
method
dilut
friend
agent
inocul
group
mice
group
split
equal
part
give
two
set
titrat
uninocul
control
group
set
eight
day
later
mice
one
set
inocul
usual
dose
hepat
die
survivor
kill
sixth
day
score
describ
method
mice
duplic
set
also
kill
day
inocul
friend
agent
indic
earlier
mous
whose
spleen
heavier
g
consid
posit
result
shown
tabl
ii
indirect
method
g
spleen
direct
method
g
spleen
preliminari
experi
moloney
agent
show
enhanc
thevirul
provid
inocul
babi
mice
day
beforeth
inocul
one
experi
group
babi
mice
inocul
suspens
infect
moloney
lymph
node
mll
one
die
lactat
rest
wean
day
old
given
usual
inocul
kill
day
frienid
inocul
consid
infect
friend
agelnt
spleen
weight
g
mhv
six
die
acut
hepat
day
liver
remaind
kill
day
score
anoth
experi
babi
mice
inocul
moloney
suspens
mi
follow
mhvi
day
later
kill
show
sever
hepat
score
attempt
made
titrat
moloney
agent
potenti
group
contain
babi
mice
inocul
dilut
oloney
lymph
node
prepar
group
similar
mice
receiv
inocul
ss
broth
twentysix
day
later
mice
inocul
usual
dose
six
day
degre
hepat
score
usiual
way
result
shown
tabl
iii
infect
rate
mice
infect
mice
group
g
direct
titratioin
infect
rate
mice
infect
mice
group
g
tissu
anoth
indirect
titrat
group
babi
mice
inocul
dilut
moloney
suspens
twenti
day
later
inocul
mhvi
degre
hepat
score
day
result
verv
similar
last
experi
shown
briefli
tabl
tabl
iv
mean
base
two
less
observ
led
g
tissu
experi
took
day
order
obtain
direct
titrat
dilut
moloney
agent
use
experi
also
inocul
group
babi
swiss
mice
indic
method
diagnosi
leukaemia
base
upon
lesion
mice
kill
currenc
experi
survivor
sacrif
termin
day
result
shown
detail
tabl
iv
led
g
tissu
enhanc
pathogen
mhv
infecti
agent
e
coccoid
suggest
enhanc
produc
tissu
prepar
contain
friend
moloney
leukaemia
agent
may
due
infecti
agent
view
support
fact
even
dilut
prepar
contain
friend
moloney
agent
enhanc
observ
moloney
agent
must
inocul
long
day
increas
pathogen
furthermor
fact
thatfor
enhanc
time
preinocul
prepar
contain
friend
agent
moloney
agent
consider
differ
suggest
differ
infecti
agent
oper
case
indirectli
support
content
friend
agent
moloney
agent
respons
enhanc
nevertheless
possibl
enhanc
due
factor
present
prepar
exclud
purifi
prepar
friend
moloney
agent
avail
eperythrozoon
coccoid
enhanc
pathogen
mh
periodl
high
concentr
parasit
mous
tissu
gledhil
also
true
enhanc
friend
molonev
agent
would
impli
friend
agent
attain
high
titr
day
moloney
agent
abouit
week
point
interest
especi
case
moloney
agent
viru
would
present
high
titr
long
sign
leukaemia
appear
exampl
might
certain
cellviru
relationship
infrequ
occurr
requir
produc
initi
leukaem
cell
inde
case
well
adapt
virus
multipli
long
period
time
littl
direct
pathogen
action
might
potenti
agent
tumour
product
capacitv
moloney
agenit
potenti
less
mark
friend
agent
e
coccoid
nevertheless
suffici
obtain
titrat
within
month
sinc
time
produc
leukaemia
long
indefinit
appear
consider
practic
valu
would
interest
determin
whether
mous
tumour
virus
potenti
smaller
amount
splenic
enlarg
inocul
day
friend
agent
could
perhap
ascrib
form
viral
interfer
smaller
amount
splenic
enlarg
probabl
occur
inocul
day
friend
agent
difficult
explain
might
due
capac
parasitis
inhibit
divis
tumour
cell
experi
determin
whether
mhvi
interfer
moloney
agent
way
friend
agent
undertaken
unless
interfer
much
stronger
toward
friend
agent
would
difficult
detect
sinc
onset
leuikaemia
occuir
time
scatter
sever
month
sunimari
wahen
friend
leukaemia
agent
inocul
intraperiton
weanl
mice
least
day
intraperiton
inocul
mous
hepat
viru
pathogen
latter
viru
much
increas
similar
somewhat
less
mark
enhanc
pathogen
mhvi
occur
day
old
mice
inocul
moloney
leukaemia
agent
day
inocul
magnitud
potenti
mhvi
friend
moloney
agent
depend
strain
mice
employ
case
greater
albani
swiss
mice
potenti
mhv
l
two
agent
provid
indirect
method
titrat
suspens
friend
agent
g
spleen
obtain
compar
g
direct
method
base
upon
splenic
enlarg
two
differ
suspens
moloney
agent
yield
g
tissu
indirect
method
latter
suspens
titrat
direct
method
gave
g
took
day
compar
day
indirect
titrat
mhvi
given
day
friend
agent
reduc
amount
splenic
enlarg
friend
agent
produc
day
given
day
friend
agent
also
reduc
spleen
weight
given
period
day
day
friend
inocul
reduc
amount
splenic
enlarg
